Additionally, the majority of MECP2 mutations in RTT are loss-of-function mutations, but overexpression of MECP2 by gene duplication in a mouse model [73], as well as in human clinical cases [74]–[77], also causes mental retardation and progressive neurological diseases. The gene discussed is MECP2; the disease is nervous system disorder.